In:
Cancer, Wiley, Vol. 122, No. 23 ( 2016-12), p. 3682-3686
Abstract:
The objective of cervical screening is to detect and treat precancer to prevent cervical cancer mortality and morbidity while minimizing overtreatment of benign human papillomavirus infections and related minor abnormalities. Human papillomavirus/cytology cotesting at extended 5‐year intervals currently is a recommended screening strategy in the United States, but the interval extension is controversial. The results of the current study indicate that repeated cotesting at 3‐year intervals lowers population rates of cancer, but leads to a greater number of colposcopy examinations required to detect a single precancer. See also pages 3596‐7.
Type of Medium:
Online Resource
ISSN:
0008-543X
,
1097-0142
DOI:
10.1002/cncr.v122.23
Language:
English
Publisher:
Wiley
Publication Date:
2016
detail.hit.zdb_id:
1479932-7
detail.hit.zdb_id:
2599218-1
detail.hit.zdb_id:
2594979-2
detail.hit.zdb_id:
1429-1